Chemomab Therapeutics (CMMB) Return on Equity [ROE] (2019 - 2026)
Chemomab Therapeutics (CMMB) posted Return on Equity [ROE] of 77.95% for Q2 2026, down 39.77 percentage points from 117.72% a year earlier but up 13.29 percentage points from the prior quarter.
Powered by 
Analysis
Chemomab Therapeutics (CMMB) Return on Equity [ROE] (2019 - 2026) Analysis & Trends
For FY2025, Chemomab Therapeutics' Return on Equity [ROE] came in at 69.54%, down 21.80 percentage points from FY2024.
- Annual Return on Equity [ROE] shows a four-year change of +35.00 percentage points (FY2021 to FY2025).
- In prior years, Chemomab Therapeutics' Return on Equity [ROE] was 91.34% in FY2024 (+0.32 pp), 91.02% in FY2023 (+32.24 pp), 58.79% in FY2022 (+24.25 pp) and 34.53% in FY2021.
- Quarterly Return on Equity [ROE] has run from a low of 2.76% in Q3 2021 to a high of 145.16% in Q3 2023 over five years.
- On a year-over-year basis, Return on Equity [ROE] has declined in each of the last nine quarters, with an average year-over-year change of -28.18 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q2 2023, with a gain of 96.85 percentage points; the weakest was Q1 2026, with a drop of 47.34 percentage points.
- According to Business Quant data, Return on Equity [ROE] for the three prior quarters was 64.66% (Q1 2026), 76.34% (Q4 2025) and 96.37% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Chemomab Therapeutics | 8.56 Mn | 8.56 Mn | - | 77.95% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 77.95% |
| Mar 31, 2026 | 64.66% |
| Dec 31, 2025 | 76.34% |
| Sep 30, 2025 | 96.37% |
| Jun 30, 2025 | 117.72% |
| Mar 31, 2025 | 111.99% |
| Dec 31, 2024 | 93.42% |
| Sep 30, 2024 | 109.49% |
| Jun 30, 2024 | 129.58% |
| Mar 31, 2024 | 127.79% |
| Dec 31, 2023 | 138.25% |
| Sep 30, 2023 | 145.16% |
| Jun 30, 2023 | 131.93% |
| Mar 31, 2023 | 100.72% |
| Dec 31, 2022 | 45.78% |
| Sep 30, 2022 | 62.56% |
| Jun 30, 2022 | 35.07% |
| Mar 31, 2022 | 15.30% |
| Dec 31, 2021 | 7.84% |
| Sep 30, 2021 | 2.76% |
API Access
Chemomab Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CMMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "CMMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CMMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();